Lupin shares in focus after FDA approval for generic HIV tablets

Lupin Share Price: Indian pharmaceutical giant Lupin gained US FDA approval for its generic version of Gilead Sciences' HIV drug Descovy. This win grants Lupin 180 days of shared exclusivity in the US market, a significant boost for the company. The generic drug will be produced at Lupin's Nagpur facility. Lupin's shares saw a 2.